If the same promising results are confirmed in prospective studies, TMB will become an indispensable biomarker for UC patients independent of the other predictive biomarkers, including PD-L1 expression, mismatch repair deficiency, microsatellite instability, and the tumor microenvironment. Here, CD274 is linked to neoplasm.